GNQ Insilico and IBM Collaborate to Advance Precision Medicine and Clinical AI Adoption In a significant move aimed at transforming the future of healthcare and drug development, GNQ Insilico has…
Blaine Labs Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination Blaine Labs, Inc., a healthcare products manufacturer based in Santa Fe Springs, California, has announced…
Vyome to Present Full Phase 2 Clinical Data on VT-1953 for Malignant Fungating Wounds at AACR 2026 Vyome Holdings, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies…
PureTech Founded Entity Seaport Therapeutics Publishes First-in-Human Data on GlyphAllo™ (SPT-300) in Science Translational Medicine PureTech Health plc a biotherapeutics company focused on advancing innovative science into impactful medicines, announced…
FDA Accepts Application Covering 64 SKUs, Moving Sesh Closer to Potential Marketing Authorization Sesh Products US, Inc. has announced a significant regulatory milestone in its efforts to bring its nicotine…
Gilead Sciences Moves to Acquire Ouro Medicines, Strengthening Its Autoimmune and Inflammation Pipeline with Innovative T-Cell Engager Technology Gilead Sciences has announced a major strategic step to expand its presence…
Biocytok and Moonlight Bio Collaborate to Advance Cell Therapy with Fully Human Antibody Library Biocytogen (Beijing) Pharmaceutical Technology a globally focused biotechnology company known for its innovative platforms in drug…
Aptar’s Introduction to INNA-051 Investigational Nasal Spray AptarGroup a global leader in drug delivery, dosing, and protection technologies, has announced the use of its Unidose (UDS) Powder Nasal Spray System…
Exact Sciences Highlights Advances in MRD and Multi-Cancer Early Detection at AACR 2026 Exact Sciences Corp. is set to present significant new data at the AACR Annual Meeting 2026, underscoring…
United Therapeutics Corporation Shares TETON-2 Phase 3 Trial Findings in The New England Journal of Medicine United Therapeutics Corporation announced that the complete findings from its Phase 3 TETON-2 clinical…
IFF Expands Production and Innovation Capabilities in Latin America with New Enzyme Hub and Applications Laboratory Global ingredients and biosciences leader IFF is strengthening its footprint in Latin America through…
Parabilis Medicines Reports Early Clinical Evidence that Zolucatetide Reduces Polyp Burden in a Patient with Familial Adenomatous Polyposis Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for…